|
|
|
|
Category Returns
|
|
|
MF Scheme SnapShots |
Check out details of a particular scheme along with the latest NAV for various time
periods. You can widen your search on the basis of the Fund House, Category and
particular Scheme
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
|
|
Summary
|
|
Fund Name
|
ICICI Prudential Mutual Fund
NA |
Scheme Name
|
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)
|
AMC
|
ICICI Prudential Asset Management Company Limited
|
Type
|
Open ended scheme
|
Category
|
Equity - Sectoral Fund - Pharma & Health Care
|
Launch Date |
13-Jul-18
|
Fund Manager
|
Dharmesh Kakkad
|
Face Value
|
10
|
Custodian |
HDFC Bank Limited , Citibank N.A
|
Net Assets (Rs. cr)
|
4807.86
|
|
|
|
AMC Details |
ICICI Prudential Asset Management Company Limited
|
One BKC, A - Wing 13th Floor,
|
Bandra Kurla Complex, Bandra (East)
|
Mumbai - 400 051
|
Phone :
+91 (22) 2652 5000
|
Fax :
+91 (22) 2652 8100
|
enquiry@icicipruamc.com
|
www.icicipruamc.com
|
|
Registrar & Transfer Agent Details |
Computer Age Management Services Limited
|
178 / 10, Kodambakkam High Road,
|
Opp. Palmgroove Hotel, M.G.R. Salai, Nungambakkam,
|
Chennai - 600 034
|
(044) 39115574, 39115583
|
(044) 28291521
|
camslb@camsonline.com
|
www.camsonline.com
|
|
|
|
|
|
|
|
NAV Details
|
|
NAV Date
|
27-Sep-24 |
Max Entry Load %
|
0.00 |
NAV [Rs] |
39.07 |
Max Exit Load %
|
1.00 |
Buy/Resale Price [Rs]
|
39.07 |
52 Week High[Rs] |
39.26 (12-Sep-24) |
Sell/Repurchase Price [Rs]
|
39.07 |
52 Week Low[Rs]
|
23.23 (26-Oct-23) |
|
|
NAV Graph |
|
|
|
|
|
|
|
|
|
|
|
Investment Details
|
Objective |
To generate long-term capital appreciation by creating a portfolio that is invested in Equity and Equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.However there can be no assurance that the investment objectives of the scheme will be realized. |
|
|
Min. Investment (Rs.)
|
5000 |
Increm.Investment (Rs.)
|
1000 |
|
|
Investment Pattern |
Type | Minimum % | Maximum % | Equity & Equity related instruments of pharma, healthcare, diagnostics, wellness & allied comp | 80 | 100 | Equity & Equity related instruments ofother than pharma, healthcare, diagnostics, wellness and allied comp | 0 | 20 | Debt, Units of MF Schemes, MMI, Cash & Cash Equivalents | 0 | 20 |
|
|
|
SIP Details |
|
SIP MIN Investments(Rs.) |
500 |
SIP Incremental Investments(Rs.) |
1 |
SIP Frequency |
Daily |
No.of Investments Cheques
|
|
|
|
|
|
|
Ratio
|
Statistical Ratios |
|
Beta [%] |
0.4629
|
Sharpe Ratio [%] |
1.2999
|
R-Square [%] |
0.5078
|
Expense Ratio [%] |
1.9300
|
AVG Ratio [%] |
0.1117
|
|
|
Other Ratios |
|
Treynor Ratio [%] |
0.4105
|
Turnover Ratio [%] |
0.8600
|
FAMA Ratio [%] |
0.1427
|
SORTINO Ratio [%] |
0.1787
|
|
|
|
|
What is Standard Deviation? Standard Deviation is the measure of the deviation in the returns of the portfolio. In Simple Words it tells us how much the return on the fund is deviating from the expected normal return.
|
|
What is Jenson's Alpha? It measures whether the Scheme is generating excess returns over the normal returns.For example, if there are two mutual funds that both have a 12% return, a rational investor will want the fund that is less risky.If the value is positive, then the portfolio is earning excess returns. In other words, a positive value for Jensen's alpha means a fund manager has 'beat the market' w with his or her stock picking skills. The Higher the value the better the performance.
|
|
|
|
|
Portfolio Analysis
|
Allocations As on
31-Aug-2024
|
|
Fund Size :
4807.86
(Cr.) |
|
|
|
|
|
Market cap-wise Allocation Style |
|
Average Mkt Cap (Rs Cr) |
51698.67
|
Market Capitalization |
% of Portfolio
|
Large |
87.50
|
Mid |
4.72
|
Small |
1.46
|
Note: Large-Cap = 5000 Crs. and above, Mid-Cap = 2000 Crs. to 5000 Crs. and
Small-Cap = less than 2000 Crs. |
|
|
|
Portfolio Concentration |
|
% Net Assets
|
Top 3 Sectors |
NA |
|
+ - Top 5 Holdings |
40.85 |
Sun Pharma Inds. | 15.16 | Tri-Party Repo (TREP | 7.36 | Cipla | 6.77 | Dr. Reddy's Lab | 6.65 | Lupin | 4.92 |
|
+ - Top 10 Holdings |
61.46 |
Sun Pharma Inds. | 15.16 | Tri-Party Repo (TREP | 7.36 | Cipla | 6.77 | Dr. Reddy's Lab | 6.65 | Lupin | 4.92 | Gland Pharma | 4.91 | Aurobindo Pharma | 4.75 | Apollo Hospital Ent. | 4.42 | Mankind Pharma | 3.75 | Divi's Lab | 2.78 |
|
|
|
|
Sun Pharmaceutical Industries Ltd.
|
15.16
|
Tri-Party Repo (TREPS)
|
7.36
|
Cipla Ltd.
|
6.77
|
Dr. Reddy's Laboratories Ltd.
|
6.65
|
Lupin Ltd.
|
4.92
|
Gland Pharma Ltd.
|
4.91
|
Aurobindo Pharma Ltd.
|
4.75
|
Apollo Hospitals Enterprise Ltd.
|
4.42
|
Mankind Pharma Ltd.
|
3.75
|
Divi's Laboratories Ltd.
|
2.78
|
|
|
Indicates an increase
or decrease or no change in holding since last portfolio
|
Indicates a new
holding since last portfolio.
|
|
Detailed Portfolio |
|
|
Sector Allocation * (as % of equity portfolio) |
|
Sector Allocation
  Chart Type : |
|
*Pertains to the equity investments only. |
|
|
|
|
|
In / Out
|
What's in as on 31-Aug-2024 |
What's out as on 31-Aug-2024 |
Company Name | Mkt Value | Holdings | | (Rs.Cr) | % | Abbott India Ltd. | 12.7396 | 0.265 | Hikal Ltd. | 11.0292 | 0.2294 | Alembic Pharmaceuticals Ltd. | 17.9538 | 0.3734 | Medplus Health Services Ltd. | 115.9584 | 2.4118 |
|
Company Name | Mkt Value | Holdings | | (Rs.Cr) | % | Ajanta Pharma Ltd. | 32.6509 | 0.7255 | Laxmi Organic Industries Ltd. | 12.201 | 0.2711 | HDFC Life Insurance Company Ltd. | 52.6463 | 1.1699 | Rainbow Children's Medicare Ltd. | 11.8455 | 0.2632 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|